 | AP-306-U | Human Colorectal Cancer WiDr Cell Line (HEW-K16), Peptide Aptamer, unlabeled | 5 mg | Sign In for Pricing | |
 | abx269927 | Receptor-Binding Cancer Antigen Expressed On SiSo Cells (EBAG9) Peptide | 100 µg | Sign In for Pricing | |
 | MBS9619838-01 | SNCG (breast cancer-specific protein 1) Blocking Peptide | 1 mg | Sign In for Pricing | |
 | MBS9619838-02 | SNCG (breast cancer-specific protein 1) Blocking Peptide | 5x 1 mg | Sign In for Pricing | |
 | 147849 | DLC-1, Control Peptide (Rho GTPase-activating Protein 7, Deleted in Liver Cancer 1 Protein, HP Protein, Rho-type GTPase-activating Protein 7, START Domain-containing Protein 12, StARD12, StAR-related Lipid Transfer Protein 12, DLC1, ARHGAP7, KIAA1723, STARD12) | 100 µg | Sign In for Pricing | |
 | 147918 | FAPP2, Control Peptide (Pleckstrin Homology Domain-containing Family A Member 8, PH Domain-containing Family A Member 8, Phosphatidylinositol-four-phosphate Adapter Protein 2, FAPP-2, Phosphoinositol 4-phosphate Adapter Protein 2, hFAPP2, Serologically Defined Breast Cancer Antigen NY-BR-86, PLEKHA8, MGC3358, DKFZp313M1034, DKFZp686J09164) | 100 µg | Sign In for Pricing | |
 | 148615 | TPTE, Control Peptide (Transmembrane Phosphatase with Tensin Homology, Cancer/Testis Antigen 44, CT44, PTEN2, Putative Tyrosine Protein Phosphatase, Tumor Antigen BJ-HCC-5) | 100 µg | Sign In for Pricing | |
 | 148719 | CEP290, Control Peptide (Centrosomal Protein of 290kD, Cep290, Bardet-Biedl Syndrome 14 Protein, Cancer/Testis Antigen 87, CT87, Nephrocystin-6, Tumor Antigen se2-2, BBS14, KIAA0373, NPHP6, FLJ13615, FLJ21979, JBTS5, JBTS6, 3H11Ag) | 100 µg | Sign In for Pricing | |
 | 149304 | ANO1, Control Peptide (Anoctamin-1, Discovered on Gastrointestinal Stromal Tumors Protein 1, Oral Cancer Overexpressed Protein 2, Transmembrane Protein 16A, Tumor-amplified and Overexpressed Sequence 2, DOG1, ORAOV2, TAOS2, TMEM16A, FLJ10261) | 50 µg | Sign In for Pricing | |
 | 149479 | CRISP2, Control Peptide (Cysteine-rich Secretory Protein 2, CRISP-2, Cancer/Testis Antigen 36, CT36, Testis-specific Protein TPX-1, GAPDL5, TPX1) | 50 µg | Sign In for Pricing | |
 | N5379-06-P | N33 (TUSC3, tumor suppressor candidate 3, D8S1992, MGC13453, N33, OST3A, Putative prostate cancer tumor suppressor) (Control Peptide) discontinued | 100 µg | Sign In for Pricing | |
 | AP-305-U | Breast Cancer Cells (a-peptide 18), Peptide Aptamer, unlabeled | 5 mg | Sign In for Pricing | |
 | AP-305-B | Breast Cancer Cells (a-peptide 18), Peptide Aptamer, Biotinylated | 1 mg | Sign In for Pricing | |
 | CRB1000940-01 | ARF peptide - (Cancer Peptides) | 0.5 mg | Sign In for Pricing | |
 | CRB1000940-02 | ARF peptide - (Cancer Peptides) | 1 mg | Sign In for Pricing | |
 | CRB1001174-01 | FREG peptide - (Cancer Peptides) | 0.5 mg | Sign In for Pricing | |
 | CRB1001174-02 | FREG peptide - (Cancer Peptides) | 1 mg | Sign In for Pricing | |
 | 148198 | MUC13, Control Peptide (Mucin-13, MUC-13, Down-regulated in Colon Cancer 1, DRCC1, RECC, UNQ6194/PRO20221, FLJ20063) | 100 µg | Sign In for Pricing | |
 | abx616792 | Serologically Defined Colon Cancer Antigen 8 (SDCCAG8) Peptide | 100 µg | Sign In for Pricing | |
 | CRB1001405-01 | Bim BH3, Peptide IV - (Cancer Peptides) | 0.5 mg | Sign In for Pricing | |
 | CRB1001405-02 | Bim BH3, Peptide IV - (Cancer Peptides) | 1 mg | Sign In for Pricing | |
 | 147705 | BCAR3, Control Peptide (Breast Cancer Anti-estrogen Resistance Protein 3, Novel SH2-containing Protein 2, SH2 Domain-containing Protein 3B, NSP2, SH2D3B, UNQ271/PRO308) | 100 µg | Sign In for Pricing | |
 | 148045 | NDC80, Control Peptide (Kinetochore Protein NDC80 Homolog, Highly Expressed in Cancer Protein, Kinetochore Protein Hec1, HsHec1, Kinetochore-associated Protein 2, Retinoblastoma-associated Protein HEC, HEC, HEC1, KNTC2) | 100 µg | Sign In for Pricing | |
 | abx615151 | Colon Cancer-Associated Protein Mic1 (MIC1) Peptide | 100 µg | Sign In for Pricing | |
 | HY-P10790 | Breast cancer targeting peptide 18–4 | 1 Each | Sign In for Pricing | |
 | AP-305-F | Breast Cancer Cells (a-peptide 18), Peptide Aptamer, FITC labelled | 1 mg | Sign In for Pricing | |
 | L-015 | Cancer-Targeting Peptide Library | 289 Peptides | Sign In for Pricing | |
 | AB-23033-P | Zebra fish breast cancer 2, early onset (BRCA2) Control/blocking peptide | 100 µg | Sign In for Pricing | |
 | AP-313-B | Human Breast Cancer Xenografts (RGD-4C), Peptide Aptamer, Biotinylated | 1 mg | Sign In for Pricing | |
 | abx616881 | Hypermethylated In Cancer 1 Protein (HIC1) Peptide | 100 µg | Sign In for Pricing | |
 | MBS1205116-01 | Recombinant Cancer pagurus CHH precursor-related peptide | 0.05 mg (E-Coli) | Sign In for Pricing | |
 | MBS1205116-02 | Recombinant Cancer pagurus CHH precursor-related peptide | 0.2 mg (E-Coli) | Sign In for Pricing | |
 | MBS1205116-03 | Recombinant Cancer pagurus CHH precursor-related peptide | 0.05 mg (Yeast) | Sign In for Pricing | |
 | MBS1205116-04 | Recombinant Cancer pagurus CHH precursor-related peptide | 0.5 mg (E-Coli) | Sign In for Pricing | |
 | MBS1205116-05 | Recombinant Cancer pagurus CHH precursor-related peptide | 0.05 mg (Baculovirus) | Sign In for Pricing | |
 | MBS1205116-06 | Recombinant Cancer pagurus CHH precursor-related peptide | 0.2 mg (Yeast) | Sign In for Pricing | |
 | MBS1205116-07 | Recombinant Cancer pagurus CHH precursor-related peptide | 1 mg (E-Coli) | Sign In for Pricing | |
 | MBS1205116-08 | Recombinant Cancer pagurus CHH precursor-related peptide | 0.5 mg (Yeast) | Sign In for Pricing | |
 | MBS1205116-09 | Recombinant Cancer pagurus CHH precursor-related peptide | 0.1 mg (Baculovirus) | Sign In for Pricing | |
 | MBS1205116-10 | Recombinant Cancer pagurus CHH precursor-related peptide | 0.05 mg (Mammalian-Cell) | Sign In for Pricing | |
 | MBS1205116-11 | Recombinant Cancer pagurus CHH precursor-related peptide | 1 mg (Yeast) | Sign In for Pricing | |
 | MBS1205116-12 | Recombinant Cancer pagurus CHH precursor-related peptide | 0.5 mg (Baculovirus) | Sign In for Pricing | |
 | MBS1205116-13 | Recombinant Cancer pagurus CHH precursor-related peptide | 0.1 mg (Mammalian-Cell) | Sign In for Pricing | |
 | MBS1205116-14 | Recombinant Cancer pagurus CHH precursor-related peptide | 1 mg (Baculovirus) | Sign In for Pricing | |
 | TP3074-01 | Breast cancer targeting peptide 18–4 | 10 mg | Sign In for Pricing | |
 | TP3074-02 | Breast cancer targeting peptide 18–4 | 50 mg | Sign In for Pricing | |
 | 220316 | TFF2, Recombinant, Human (SP, SML1, TFF-2, Trefoil Factor 2, Trefoil Factor peptide, pS2 protein, HP1.A, Breast Cancer Estrogen-Inducible protein, BCEI, PNR2) discontinued | 20 µg | Sign In for Pricing | |
 | 147875 | EBAG9, Control Peptide (Estrogen Receptor-binding Fragment-associated Gene 9 Protein, EB9, Cancer-associated Surface Antigen RCAS1, PDAF, Receptor-binding Cancer Antigen Expressed on SiSo Cells, RCAS1) | 100 µg | Sign In for Pricing | |
 | 148183 | MIC1, Control Peptide (Uncharacterized Protein C18orf8, Colon Cancer-associated Protein Mic1, Mic-1, C18orf8, FLJ23453) | 100 µg | Sign In for Pricing | |
 | 148687 | XAGE1, Control Peptide (G Antigen Family D Member 2, Cancer/Testis Antigen 12.1, CT12.1, Protein XAGE-1, XAGE1A, GAGED2, XAGE1B, XAGE1C, XAGE1D, XAGE1E) discontinued | 100 µg | Sign In for Pricing | |